iBio, Inc. (IBIO)
1.665
-0.04
(-2.63%)
USD |
NASDAQ |
May 11, 12:56
iBio EPS Diluted (Quarterly) : -0.0907 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.993M |
| Total Expenses (Quarterly) | 8.993M |
| Enterprise Value | 8.822M |
| Earnings Yield | -60.42% |
| Normalized Earnings Yield | -59.36 |